Download Brochure
Fill in your details to get instant access
We respect your privacy. No spam, ever.
Conference Overview
The 42nd Pharmacovigilance India 2026 serves as a premier platform for industry leaders to exchange insights and strengthen safety strategies within India’s rapidly evolving drug safety landscape. The event focuses on the future of pharmacovigilance, highlighting the integration of digital innovation and robust regulatory oversight to support the global pharmaceutical industry.
Digital Transformation
The conference explores how AI-driven signal detection, automation, and machine learning are redesigning pharmacovigilance. Sessions will examine the shift from periodic reviews to continuous risk intelligence through human-AI collaboration.
Regulatory Evolution
Experts will discuss driving compliance and collaboration between industry and regulators to achieve safer drugs. The agenda includes navigating global regulatory trends and the evolving ecosystem of combination products.
Risk Management
Attendees will focus on strengthening benefit-risk frameworks and reimagining risk management in PV. This includes exploring new approaches to drug safety to ensure enhanced patient protection.
Outsourcing Strategies
The event addresses the future of pharmacovigilance outsourcing, specifically balancing efficiency, quality, and compliance. It also highlights India’s growing role as a global hub for these critical outsourced services.
Data Intelligence
A major focus is placed on the growing role of Real-World Evidence (RWE) and Real-World Data (RWD) in modern drug safety. Professionals will learn how to harness these data sources to strengthen patient safety and clinical research.
Audit Readiness
Participants will learn to plan, develop, and implement robust PV audit strategies to ensure continuous inspection readiness. Discussions will cover common inspection findings and leveraging digital tools for compliance oversight.
Download Brochure
Fill in your details to get instant access
We respect your privacy. No spam, ever.
42nd Pharmacovigilance India 2026: Navigating the Future of Drug Safety
The 42nd Pharmacovigilance India 2026, presented by Virtue Insight, convenes on 23 July 2026 at the Radisson in Hyderabad. As India’s PV market is projected to exceed USD 700 million by 2033, this forum addresses the critical need for robust safety surveillance. Industry leaders from global giants like Amgen, Novartis, and Pfizer will share strategic insights on digital transformation. Attendees will explore high-impact topics including AI-driven signal detection, RWE, and evolving regulatory frameworks. This conference offers a unique, discussion-driven environment designed to strengthen safety strategies and foster elite partnerships across the pharmaceutical ecosystem
Speakers
Attendees
Hrs NETWORKING
SESSIONS
OUR ATTENDEES
Trusted by Industry Leaders Worldwide
REGISTER ATTEND LEARN NETWORK SUCCEED
5 reasons to attend the events
Harness the power of AI-driven innovation and strategic global partnerships to redefine the future of drug safety. Join industry pioneers in Hyderabad to navigate evolving regulatory landscapes and ensure unparalleled patient protection in the digital age.
Elite Networking
Connect with senior-level executives and decision-makers from global leaders like Amgen, Novartis, and Pfizer in a focused, discussion-driven environment.
AI Integration
Explore how intelligent drug safety and autonomous signal intelligence are redesigning pharmacovigilance workflows through human-AI collaboration.
Regulatory Mastery
Gain critical updates on global regulatory trends, combination products, and strategies for achieving continuous inspection readiness.
Strategic Outsourcing
Evaluate the future of PV outsourcing in India, focusing on balancing operational efficiency with high-quality compliance standards.
Data-Driven Safety
Learn to harness Real-World Evidence (RWD/RWE) and advanced risk management frameworks to strengthen benefit-risk outcomes for patients
Meet Our Expert Speakers
OUR EVENT SCHEDULE
08:30 – Coffee and Registration – An opportunity to meet, greet & network with your conference colleagues.
09:00 – Welcome address and Opening Remarks
Speaker TBC
Clinevo Technologies
DIVAKAR KOLLI
Cipla
09:05 – Special Address by the Guest of Honour
- Understanding the True Intent of ICH E6(R3)
- Identifying Current Implementation Gaps
- Commonly Overlooked Elements in R3
- Practical Barriers Across Sponsors, CROs, and Sites
- Actionable Strategies to Bridge the Gap
SARVESH SINGH
Telangana Lifesciences
GLOBAL ECOSYSTEM / COMBINATION PRODUCTS
09:20 – Keynote Address – The evolving Global Ecosystem and world of Combination Products
Explore the definitions and global regulatory trends currently shaping the combination products ecosystem. Highlighting the universal challenges
impacting industry stakeholders, regulators, and suppliers, while sharing best practices for navigating future innovations and ecosystem shifts. Emphasize
the role India (People, Process and Technology) plays in the evolution
KHAUDEJA BANO
Roche – Genentech (USA)
09:50 – Keynote- Intelligent Drug Safety: How AI is Redesigning Pharmacovigilance
Explore the definitions and global regulatory trends currently shaping the combination products ecosystem. Highlighting the universal challenges
impacting industry stakeholders, regulators, and suppliers, while sharing best practices for navigating future innovations and ecosystem shifts. Emphasize
the role India (People, Process and Technology) plays in the evolution
SIVA KUMAR BUDDHA
Amgen
TRANSFORMING PV OUTSOURCING
10:10 - Keynote Panel Discussion – Future of Pharmacovigilance Outsourcing: Balancing efficiency, quality, and compliance. India as a global Hub for Pharmacovigilance Outsourcing
Moderator
SIVA KUMAR BUDDHA
Amgen
Panellists
PRASAD DESHMUKH
Cipla
RAJESH RAJENDRAN
Pfizer
JOSE ALBERTO AYALA ORTIZ
PVpharm (Spain)
SAILAJA SAYANA
Sandoz
SHUBHAM MITTAL
Nextrove
10:50 – MORNING COFFEE/TEA & NETWORKING
RMP – INNOVATION, INSIGHTS, IMPACT
11:20 – Discussion With Experts – Reimagining Risk Management in PV. Strengthening Benefit–Risk Frameworks for Safer Medicines & new approaches in drug safety & risk management
Moderator
ANUJA JAWALE
Kenvue
Panellists
KABIL KALATHINGAL
Dr. Reddy’s Laboratories
MOHIT TRIVEDI
Sanofi
DEVANG PATEL
Zydus Group
12:00 – Topic TBC
Speaker TBC
Clinevo Technologies
JASON BRYANT
CSL Behring
12:20 – Automated Literature Screening and Extraction
Speaker TBC
Clinevo Technologies
BHAVISHYA SALUJA
Ultragenic
12:40 – Networking luncheon
GCC IN PHARMA / DIGITAL TRANSFORMATION
13:40 – Discussion With Experts – Driving AI, automation, & the future of PV. GCCs in the Digital Age: How GCCs are powering the next generation of drug safety? From back office to innovation hub
Moderator
ASHISH DWIVEDI
Synapmed
Panellists
KIRAN KANDULA
Astrazeneca
NUPUR SONI
Amgen
VIKRAM K
Bristol Myers Squibb
SHWETHA SUBRAMANYA
Novartis
AUDITS / INSPECTION
14:20 – PV Audits & Inspections - Plan, Develop & Implement the PV Audit strategy plan. PV Inspection readiness: What to expect? How ready can we be?
- Ensuring Compliance, Quality, and Continuous Improvement
- Common pharmacovigilance inspection findings and how organizations can proactively address them
- Building a robust PV (QMS) to support inspection readiness
- Leveraging technology and digital tools to improve audit tracking, CAPA management, and compliance oversight
- Creating a culture of continuous inspection readiness and quality excellence in pharmacovigilance operations
SHUBHADEEP SINHA
Hetero Labs
SIGNAL
14:40 – Autonomous Signal Intelligence: Reimagining Signal Management through Human–AI Collaboration
- AI agents continuously monitor multiple safety data sources to detect emerging signals early.
- AI supports rapid triage, prioritization, and evidence synthesis at scale.
- Experts apply clinical judgment to validate and interpret AI-generated insights.
- Transparent and auditable AI workflows support regulatory confidence.
- Enabling a shift from periodic signal review to continuous risk intelligence.
SHUBHADEEP SINHA
Hetero Labs
15:00 – Afternoon Coffee/Tea & Networking
GROWING ROLE OF RWE / RWD
15:30 – Discussion With Experts – Role of RWE in Modern Pharmacovigilance. RWD in Drug Safety: Opportunities, Challenges. Harnessing them to strengthen PV and patient safety
Moderator
SHRADDHA BHANGE
Sandoz
Panellists
HANUMANTHA RAO KAREDLA
Amgen
GIRIJAA KADAM
Sanofi
KRISHNA ASVALAYAN
PwC India
PRANAV SIKKA
Novartis
HARMONIZING PV REGULATIONS
16:10 – Discussion With Experts – Regulatory Evolution in Pharmacovigilance: Driving Compliance, Collaboration, & Innovation. Collaboration between Industry & Regulators to achieve safer drugs for patients’ safety.
Moderator
VIJAY KRISHNAN
Opella
Panellists
RAJENDRA KASI
Glenmark
NITU SINHA
Mankind Pharma
SRIRAM VARMA
TECHSOL
PADMA BALAKRISHNAN
Knowledgeworks Innovative Linguistic Solutions
AUDITS / INSPECTION
16:50 – Fire Side Chat - From CAPAs to Culture: Rethinking What Makes a Vendor Truly Reliable
- CAPA effectiveness matters more than CAPA closure.
- Quality culture is a stronger predictor of compliance than audit scores alone.
- Predictive oversight can identify vendor risks before they become inspection findings.
Speakers
ROHINI PANDEY
Abbott
VIVEK GUPTA
Organon
17:10 – Closing remarks and end of conference
14:50 - Re-imagining Dossier Authoring: From Manual Compilation to AI-Assisted Authoring and Lifecycle Management
- AI-driven automation in dossier creation: Transition from time-consuming manual compilation to intelligent automation where AI tools structure, draft, and validate regulatory dossiers using pre-designed templates as per ICH guidelines and real-time data processing.
- Enhanced compliance and efficiency: AI-assisted authoring ensures alignment with global regulatory standards (e.g., EMA, USFDA, CDSCO) by auto-updating changes in guidance and improving accuracy, traceability, and submission timelines.
- Lifecycle intelligence and version management: Integrating AI into the dossier lifecycle enables continuous monitoring, smart version control, and predictive updates across product changes, fostering a fully connected regulatory ecosystem.
MANASA KASIVAJJULA
CEO and Co-Founder
DeepForrest.ai (A CtrlS Company)
Our Partners
We sincerely thank the following organizations and individuals for generously contributing their time, financial support, ideas, and dedication toward the successful conduct of the 42nd pharmacovigilance india 2026
Principal Partner
Platinum Partner
Gold Partners
Silver Partners
Exhibitors
Academic Partner
Startup Partner
Event Venue
Radisson Hyderabad Hitec City
Hyderabad
India
040 6769 6769
Get Involved
Networking App
Kindly Note!
Access to view and connect with other attendees through our mobile app will be enabled closer to the conference date.
Delegate Registrations Filled & Closed
Limited Sponsorships & Stalls Left
Booking Closed
You can simply email or call and book your conference delegate seats on:
TEL: + 91 44 4210 8101 (or) Email — info@virtueinsight.com
Accommodation
We have secured special room rates for our conference participants who wish to stay at the conference venue hotel “Radisson” during the conference dates.
Once you confirm your participation, our operations team will share the room reservation details along with the booking deadline and the special rates we’ve arranged.
Event Testimonials
United Kingdom
Block 3, 86 Coombe Road
Croydon CR0 5RA
London, UK
Asia
Plot No – 07 – 2nd Floor
Ekambaram Industrial Estate
Alapakkam, Porur Chennai,
India – 600 116
Download App